Kristi Jones serves as President, CEO and Director at NexImmune, Inc. since February 2022 and served as its Chief Operating Officer from March 2018 until February 2022. She previously served as i Senior Vice President of Business Operations and Product Development, and Chief Business Officer from Earlier in her career, Kristi was Vice President of Portfolio Strategy at AstraZeneca. and Vice President of Global Strategic Marketing at MedImmune. Prior to that, she held multiple leadership roles with increasing responsibility at Genentech where she worked for 16 years, including Head of Immunology and Ophthalmology Global Product Strategy, Ms. She serves on the Life Science Panel for Springboard Enterprises focused on start-up companies led by women and on the Cell Therapy Committee for the Alliance of Regenerative Medicine. Kristi received her Pharmacy degree from the University of Texas, College of Pharmacy and her B.S. in Biology from Texas Tech University.
Year appointed: 2022